CDTCDT Equity Inc.同业对比
CDT Equity Inc. 与Pharmaceutical Preparations的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 (Pharmaceutical Preparations)| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CDT本股 | $164493#10 | 0.0x#2 | 0.0x#2 | — | — | -120.3%#14 | — | -38.0%#4 | — | — | -100.0%#15 | — |
| BTAI | $2M#1 | — | — | 3.6x#7 | -71.7%#8 | -17.3%#11 | -7860.0%#9 | — | — | — | -98.0%#14 | — |
| OGEN | $2M#2 | 0.5x#9 | 0.6x#12 | 61.1x#11 | -71.4%#7 | 6.9%#9 | -24865.2%#10 | -26814.1%#15 | — | — | -58.2%#4 | — |
| BFRGW | $2M#3 | — | 0.3x#10 | 17.8x#10 | — | 7.1%#8 | -5652.4%#8 | -93.0%#7 | -5287.3%#5 | — | -73.3%#7 | — |
| NXTS | $2M#4 | 0.0x#6 | 1.0x#14 | 9.1x#9 | -20.2%#6 | 22.9%#6 | -2014.3%#6 | -210.2%#11 | — | 4#2 | -97.4%#13 | — |
| DCOY | $2M#5 | 0.0x#7 | 0.4x#11 | — | -100.0%#9 | 124.4%#2 | — | 289.8%#1 | — | — | -95.9%#12 | — |
| ATXI | $1M#6 | — | 2.4x#15 | 1.0x#6 | — | 75.0%#3 | -219.6%#3 | -511.2%#14 | — | — | -50.4%#2 | — |
| PTIX | $1M#7 | 0.5x#8 | 0.8x#13 | — | — | 138.1%#1 | — | 79.4%#2 | — | — | -77.9%#8 | — |
| BFRIW | $386161#8 | — | 0.1x#8 | 0.0x#2 | 11.7%#4 | 40.7%#5 | -27.2%#2 | -176.9%#9 | -712.4%#3 | — | -72.5%#6 | — |
| SXTPW | $216295#9 | — | 0.1x#9 | 0.2x#5 | 65.5%#3 | 7.3%#7 | -771.6%#4 | -281.7%#12 | -163.8%#2 | 6#1 | 9.2%#1 | — |
| SBFMW | $124463#11 | 0.0x#5 | 0.0x#5 | 0.0x#1 | 4.1%#5 | -16.4%#10 | -17.2%#1 | -21.7%#3 | -63.1%#1 | — | -83.7%#9 | — |
| CINGW | $117789#12 | — | 0.0x#6 | — | — | -35.6%#12 | — | -95.7%#8 | — | — | -87.4%#10 | — |
| KTTAW | $90219#13 | — | 0.0x#3 | 0.2x#4 | 3130.4%#1 | -46.9%#13 | -4286.7%#7 | -41.0%#6 | — | — | -89.9%#11 | — |
| ERNAW | $58930#14 | 0.0x#4 | 0.0x#7 | 0.1x#3 | 755.9%#2 | 68.4%#4 | -1601.2%#5 | -440.1%#13 | -1016.2%#4 | — | — | — |
| CDTTW | $5271#16 | 0.0x#1 | 0.0x#1 | — | — | -120.3%#14 | — | -38.0%#4 | — | — | -59.4%#5 | — |
| ASBPW | $32259#15 | 0.0x#3 | 0.0x#4 | 5.2x#8 | — | -1768.9%#16 | -312016.9%#11 | -208.2%#10 | — | — | -56.3%#3 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 数据构建于 2026-09-15。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议